Bank of New York Mellon’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-276,411
| Closed | -$4.91M | – | 4304 |
|
|
2018
Q3 | $4.91M | Buy |
276,411
+33,362
| +14% | +$593K | ﹤0.01% | 2424 |
|
|
2018
Q2 | $3.35M | Buy |
243,049
+190,537
| +363% | +$2.63M | ﹤0.01% | 2576 |
|
|
2018
Q1 | $478K | Buy |
52,512
+1,199
| +2% | +$10.9K | ﹤0.01% | 3602 |
|
|
2017
Q4 | $219K | Buy |
51,313
+16,283
| +46% | +$69.5K | ﹤0.01% | 3902 |
|
|
2017
Q3 | $49K | Hold |
35,030
| – | – | ﹤0.01% | 4105 |
|
|
2017
Q2 | $53K | Sell |
35,030
-108,522
| -76% | -$164K | ﹤0.01% | 4123 |
|
|
2017
Q1 | $369K | Buy |
143,552
+6,469
| +5% | +$16.6K | ﹤0.01% | 3678 |
|
|
2016
Q4 | $350K | Buy |
137,083
+5,537
| +4% | +$14.1K | ﹤0.01% | 3726 |
|
|
2016
Q3 | $406K | Sell |
131,546
-20,466
| -13% | -$63.2K | ﹤0.01% | 3631 |
|
|
2016
Q2 | $488K | Buy |
152,012
+3,561
| +2% | +$11.4K | ﹤0.01% | 3549 |
|
|
2016
Q1 | $460K | Buy |
148,451
+8,379
| +6% | +$26K | ﹤0.01% | 3478 |
|
|
2015
Q4 | $562K | Sell |
140,072
-70,686
| -34% | -$284K | ﹤0.01% | 3458 |
|
|
2015
Q3 | $965K | Sell |
210,758
-48,937
| -19% | -$224K | ﹤0.01% | 3188 |
|
|
2015
Q2 | $1.35M | Buy |
259,695
+25,049
| +11% | +$130K | ﹤0.01% | 3173 |
|
|
2015
Q1 | $1.47M | Buy |
234,646
+17,637
| +8% | +$110K | ﹤0.01% | 3072 |
|
|
2014
Q4 | $1.36M | Sell |
217,009
-11,871
| -5% | -$74.6K | ﹤0.01% | 3112 |
|
|
2014
Q3 | $1.39M | Buy |
228,880
+33,530
| +17% | +$204K | ﹤0.01% | 3102 |
|
|
2014
Q2 | $1.29M | Buy |
195,350
+19,371
| +11% | +$128K | ﹤0.01% | 3168 |
|
|
2014
Q1 | $4.19M | Buy |
175,979
+8,456
| +5% | +$201K | ﹤0.01% | 2418 |
|
|
2013
Q4 | $1.79M | Buy |
167,523
+6,102
| +4% | +$65.2K | ﹤0.01% | 2953 |
|
|
2013
Q3 | $2.15M | Buy |
161,421
+10,472
| +7% | +$140K | ﹤0.01% | 2801 |
|
|
2013
Q2 | $1.98M | Buy |
+150,949
| New | +$1.98M | ﹤0.01% | 2793 |
|